Evidence Level
Preliminary
Mechanism of Action
Mimics the lipolytic region of HGH. Stimulates lipolysis and inhibits lipogenesis through beta-3 adrenergic receptor interactions.
Published Research Ranges & Study Context
Studies have administered: 250–500mcg daily in research studies
Important Research Framing
These are ranges reported in published scientific studies. They are provided for educational context only and do not constitute dosing recommendations. Individual study parameters vary by design, population, and research objectives. This information is not medical advice.
Primary Research Findings
Animal studies showed significant fat reduction without insulin resistance or growth effects. Human trial data limited but phase 2/3 studies conducted.
Preliminary
Primarily preclinical + case reports
Side Effects Observed in Research
Generally well-tolerated in trials; injection site reactions
Available Configurations (SKU Reference)
5AD
Compounds Studied in Combination
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on AOD9604 — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat
Research Education Only: This compound profile is for educational purposes only. All information is sourced from published scientific literature. This is not medical advice. Not for human consumption. Consult qualified medical professionals for any health decisions. Regulatory status varies by jurisdiction.